Liraglutide Edge Over Exenatide, but GI Side Effects DoubledLiraglutide Edge Over Exenatide, but GI Side Effects Doubled
Once-daily liraglutide had the edge over once-weekly exenatide in a new head-to-head comparison of the two GLP-1 agonists in type 2 diabetes, but more patients on liraglutide had gastrointestinal side effects. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Byetta | Diabetes | Diabetes Type 2 | Endocrinology | Gastroenterology | Health | Victoza